Study of Angiotensinii Level Fluctuation in Patients with Congenital Heart Diseases Pre- and Post-Interventional Therapy

Weifeng Wang
2006-01-01
Journal of Clinical Cardiology
Abstract:Objective:To observe the change of AngiotensinⅡ(AngⅡ) in CHD pre- and post- interventional therapy, and explore its role in pulmonary hypertension with CHD. Method:Plasma AngⅡ were assayed at Pre-Interventional Therapy and at 24 hours ,1 month, 3 months, 6 months and 12 months after Interventional Therapy in 70 children with CHD:20 cases had moderate or severe pulmonary hypertension(group A) and 30 cases had slight pulmonary hypertension(group B) ,the other 20 cases had normal pressure (group C) ; and 30 cases of the control group were enrolled in the study; plasma AngⅡ were assayed at Pre-Interventional Therapy and at 24 hours ,1 month, 3 months, 6 months and 12 months after Interventional Therapy in 70 adults with CHD:20 cases had moderate or severe pulmonary hypertension(group A) and 30 cases had slight pulmonary hypertension(group B) ,the other 20 cases had normal pressure (group C) ; and 30 cases of the control group were enrolled in the study. Result:Plasma AngⅡ concentrations in group A and group B were significantly higher than that of group C(P0.01). In the three group, the plasma AngⅡ concentration begin to decrease at 1 month after Interventional Therapy, and at 12 months its concentration near the normal level. And plasma AngⅡ concentration had a positive linear correlation with PH (children group: r=0.715,P0.05; adults group, r=0.650, P0.05). Conclusion:AngⅡ may have an important role in the pathogenesis of HP.
What problem does this paper attempt to address?